Drug Pricing - MM+M - Medical Marketing and Media

Drug Pricing

All articles by Drug Pricing

‘The current system is flawed’: PhRMA’s Zirkelbach on pricing
‘The current system is flawed’: PhRMA’s Zirkelbach on pricing
Alison Kanski
November 27, 2018
4:46 pm

Robert Zirkelbach, public affairs EVP at PhRMA, discussed the group’s legislative priorities at the Coalition for Healthcare Communication’s post-election conference on Tuesday.

Pfizer to resume price increases in January
Pfizer to resume price increases in January
Alison Kanski
November 16, 2018
4:54 pm

The drugmaker will raise prices on 10% of its drug portfolio.

How to lower drug prices in the U.S.? Lots of suggestions, few viable solutions
How to lower drug prices in the U.S.? Lots of suggestions, few viable solutions
Laura Entis
November 6, 2018
9:42 am

A panel representing pharma, government payer, and policy analyst presented three potential big-picture goals to strive for.

Five things for pharma marketers to know: Monday, September 10, 2018
Five things for pharma marketers to know: Monday, September 10, 2018
Laura Entis
September 10, 2018
10:46 am

U.K. regulator rules MS drug too expensive; Memorial Sloan Kettering CEO demands more transparency from staff on financial relationships; Report: Family behind Purdue owns second opioid drugmaker.

Five things for pharma marketers to know: Friday, August 24, 2018
Five things for pharma marketers to know: Friday, August 24, 2018
Alison Kanski
August 24, 2018
2:19 pm

White House proposes rule for drug prices in DTC ads; FDA to study impact of side-effects warnings in drug ads; FDA approves Shire’s potential blockbuster HAE treatment.

Pfizer reorg came on heels of its walk-back on price hikes
Pfizer reorg came on heels of its walk-back on price hikes
Lauren Evans
July 12, 2018
4:19 pm

Wednesday’s reorg was designed to position the company for growth in the face of the imminent patent cliff for megablockbuster Lyrica.

Three quarters of Americans support listing drug prices in DTC ads: Kaiser survey
Three quarters of Americans support listing drug prices in DTC ads: Kaiser survey
Alison Kanski
June 27, 2018
7:02 pm

Across the political spectrum, most Americans favor President Donald Trump’s proposal to show drug prices in advertisements.

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners